Iroku-Malize Tochi, Kirsch Scott
Department of Family Medicine Hofstra North Shore LIJ School of Medicine Southside Hospital, 301 East Main Street Bay Shore, NY 11706.
FP Essent. 2016 Jun;445:11-6.
Glaucoma is the leading cause of irreversible vision loss in the United States, affecting 1.9% of individuals older than 40 years. The prevalence of the most common form, open-angle glaucoma, increases with age and is higher in non-Hispanic minorities. The progressive loss of peripheral vision in glaucoma often leads to difficulty with driving, particularly at night, and can increase the risk of falls and subsequent fractures. Although glaucoma usually is characterized by chronically elevated intraocular pressure, it is more accurately defined as an optic neuropathy. Typically, there are no warning signs or symptoms, and extensive and permanent optic nerve damage can occur before the patient is aware of visual field loss. A cup to disc ratio greater than 0.6 on ophthalmoscopy is suspicious for glaucoma, and visual field testing results show a characteristic peripheral loss. Medical and surgical treatments are aimed at decreasing intraocular pressure by decreasing production of aqueous humor and increasing its outflow. Drugs for glaucoma treatment include prostaglandin analogs, beta blockers, alpha2-adrenergic agonists, and carbonic anhydrase inhibitors. Surgical or laser treatment is indicated if medical management is unsuccessful. Alternative therapies are less effective and have more adverse effects than standard treatments.
青光眼是美国不可逆视力丧失的主要原因,影响着1.9%的40岁以上人群。最常见的类型——开角型青光眼的患病率随年龄增长而增加,在非西班牙裔少数族裔中更高。青光眼患者周边视力的逐渐丧失常导致驾驶困难,尤其是在夜间,还会增加跌倒及随后骨折的风险。虽然青光眼通常以眼压长期升高为特征,但更准确地说它是一种视神经病变。通常,青光眼没有警示迹象或症状,在患者意识到视野丧失之前,视神经可能已发生广泛且永久性的损伤。眼科检查时杯盘比大于0.6怀疑患有青光眼,视野测试结果显示典型的周边视野缺损。药物和手术治疗旨在通过减少房水生成和增加房水流出以降低眼压。用于治疗青光眼的药物包括前列腺素类似物、β受体阻滞剂、α2肾上腺素能激动剂和碳酸酐酶抑制剂。如果药物治疗无效,则需进行手术或激光治疗。替代疗法比标准治疗效果差且不良反应更多。